CBT
Get informed when a big investor buys or sells
+ FollowUndervalued by 209.8% based on the discounted cash flow analysis.
| Market cap | $4.11 Billion |
|---|---|
| Enterprise Value | $5.16 Billion |
| Dividend Yield | $1.84 (2.32%) |
| Earnings per Share | $6.07 |
| Beta | 0.83 |
| Outstanding Shares | 51,600,000 |
| P/E Ratio | 22.07 |
|---|---|
| PEG | -23.47 |
| Price to Sales | 1.15 |
| Price to Book Ratio | 2.45 |
| Enterprise Value to Revenue | 1.42 |
| Enterprise Value to EBIT | 10.17 |
| Enterprise Value to Net Income | 27 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.81 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0698▼ 57.80% |
|---|---|
| Total Calls | 220,700▲ 421.75% |
| Total Puts | 15,400▼ 43.80% |
Holdings and activity of institutional investors.
| Ownership % | 105.48%▲ 6.95% |
|---|---|
| Total Invested | $4.94B▲ 28.09% |
| Investors Holding | 396▲ 18.00% |
No data